Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience
Chuy K, Oikonomou EK, Postow MA, Callahan MK, Chapman PB, Shoushtari AN, Neilan TG, Fradley MG, Ramanathan LV, Wolchok JD, Steingart RM, Gupta D. Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience. The Oncologist 2019, 24: e196-e197. PMID: 30910868, PMCID: PMC6516118, DOI: 10.1634/theoncologist.2019-0040.Peer-Reviewed Original ResearchConceptsCombination immune checkpoint inhibitor therapyImmune checkpoint inhibitor therapyCheckpoint inhibitor therapyInhibitor therapyMemorial Sloan-Kettering Cancer Center experienceCancer Center experienceSafety Working GroupAdvanced melanomaCenter experienceConsensus documentPatientsTherapyWorking GroupMyocarditisMelanoma